Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-153.71%Return on Equity
VS
Market
Sector
Industry
History
$ 4.41Close
$ 2.58 - $ 5.4 52-Week Range
Ticker Information
Ticker
LTRNCompany Name
LANTERN PHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLANTERN PHARMA INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LTRN - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 12.52M | $ -19.25M | -153.71% |
| 3/31/2025 | $ 16.78M | $ -19.88M | -118.48% |
| 12/31/2024 | $ 21.19M | $ -20.78M | -98.08% |
| 9/30/2024 | $ 26.6M | $ -19.09M | -71.78% |
| 6/30/2024 | $ 30.93M | $ -17.75M | -57.38% |
| 3/31/2024 | $ 35.77M | $ -17.53M | -49.03% |
| 12/31/2023 | $ 40.91M | $ -15.96M | -39.02% |
| 9/30/2023 | $ 45.41M | $ -15.16M | -33.38% |
| 6/30/2023 | $ 48.26M | $ -14.26M | -29.55% |
| 3/31/2023 | $ 52.58M | $ -14.01M | -26.64% |
Key Performance Insights, Last 5 Years
- LANTERN PHARMA INC's latest trailing twelve months (TTM) ROE stands at 0%.
- Over the past 5 years, LANTERN PHARMA INC's average ROE has been -45.22%.
- The median ROE for LANTERN PHARMA INC during this period was -29.55%
- LANTERN PHARMA INC reached its highest ROE over the past 5 years at -9.65%.
- The lowest ROE recorded by LANTERN PHARMA INC in the same timeframe -153.71%
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for LANTERN PHARMA INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ 21.57M ]
(=) ROE [ 0% ] LTRN - Return on Equity, Last 5 years
-153.71%
Minimum
Jun 30, 2025
-9.65%
Maximum
Mar 31, 2021
-45.22%
Average
-29.55%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |